SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-116819
Filing Date
2011-04-29
Accepted
2011-04-29 07:21:33
Documents
5
Period of Report
2011-04-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 26923
2 RESTATED EXECUTIVE EMPLOYMENT AGREEMENT - ANTHONY DITONNO dex101.htm EX-10.1 56591
3 RESTATED EXECUTIVE EMPLOYMENT AGREEMENT - STEPHEN GHIGLIERI dex102.htm EX-10.2 56992
4 RESTATED EXECUTIVE EMPLOYMENT AGREEMENT - JEFFREY TOBIAS dex103.htm EX-10.3 57462
5 RESTATED EXECUTIVE EMPLOYMENT AGREEMENT - MICHAEL MARKELS dex104.htm EX-10.4 57542
  Complete submission text file 0001193125-11-116819.txt   256810
Mailing Address 2215 BRIDGEPOINTE PARKWAY SUITE 200 SAN MATEO CA 94404
Business Address 2215 BRIDGEPOINTE PARKWAY SUITE 200 SAN MATEO CA 94404 650-358-3300
NeurogesX Inc (Filer) CIK: 0001385830 (see all company filings)

IRS No.: 943307935 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33438 | Film No.: 11790914
SIC: 2834 Pharmaceutical Preparations